Table of Contents 1 Market Overview 1.1 Alzheimer’s Disease Drug Introduction 1.2 Market Analysis by Type 1.2.1 Donepezil 1.2.2 Memantine 1.2.3 Rivastigmine 1.3 Market Analysis by Applications 1.3.1 Early to Moderate Stages 1.3.2 Moderate to Severe Stages 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market States and Outlook (2012-2022) 1.4.1.2 Canada Market States and Outlook (2012-2022) 1.4.1.3 Mexico Market States and Outlook (2012-2022) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2012-2022) 1.4.2.2 France Market States and Outlook (2012-2022) 1.4.2.3 UK Market States and Outlook (2012-2022) 1.4.2.4 Russia Market States and Outlook (2012-2022) 1.4.2.5 Italy Market States and Outlook (2012-2022) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2012-2022) 1.4.3.2 Japan Market States and Outlook (2012-2022) 1.4.3.3 Korea Market States and Outlook (2012-2022) 1.4.3.4 India Market States and Outlook (2012-2022) 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2012-2022) 1.4.4.2 Egypt Market States and Outlook (2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022) 1.4.4.4 South Africa Market States and Outlook (2012-2022) 1.4.4.5 Nigeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Allergan 2.1.1 Business Overview 2.1.2 Alzheimer’s Disease Drug Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Eisai 2.2.1 Business Overview 2.2.2 Alzheimer’s Disease Drug Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Alzheimer’s Disease Drug Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Daiichi Sankyo 2.4.1 Business Overview 2.4.2 Alzheimer’s Disease Drug Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Merz Pharma 2.5.1 Business Overview 2.5.2 Alzheimer’s Disease Drug Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Pfizer 2.6.1 Business Overview 2.6.2 Alzheimer’s Disease Drug Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Johnson & Johnson 2.7.1 Business Overview 2.7.2 Alzheimer’s Disease Drug Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Lundbeck. 2.8.1 Business Overview 2.8.2 Alzheimer’s Disease Drug Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Alzheimer’s Disease Drug Market Competition, by Manufacturer 3.1 Global Alzheimer’s Disease Drug Sales and Market Share by Manufacturer 3.2 Global Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Alzheimer’s Disease Drug Manufacturer Market Share 3.3.2 Top 6 Alzheimer’s Disease Drug Manufacturer Market Share 3.4 Market Competition Trend 4 Global Alzheimer’s Disease Drug Market Analysis by Regions 4.1 Global Alzheimer’s Disease Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Alzheimer’s Disease Drug Sales by Regions (2012-2017) 4.1.2 Global Alzheimer’s Disease Drug Revenue by Regions (2012-2017) 4.2 North America Alzheimer’s Disease Drug Sales and Growth (2012-2017) 4.3 Europe Alzheimer’s Disease Drug Sales and Growth (2012-2017) 4.4 Asia-Pacific Alzheimer’s Disease Drug Sales and Growth (2012-2017) 4.5 South America Alzheimer’s Disease Drug Sales and Growth (2012-2017) 4.6 Middle East and Africa Alzheimer’s Disease Drug Sales and Growth (2012-2017) 5 North America Alzheimer’s Disease Drug by Countries 5.1 North America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries 5.1.1 North America Alzheimer’s Disease Drug Sales by Countries (2012-2017) 5.1.2 North America Alzheimer’s Disease Drug Revenue by Countries (2012-2017) 5.2 USA Alzheimer’s Disease Drug Sales and Growth (2012-2017) 5.3 Canada Alzheimer’s Disease Drug Sales and Growth (2012-2017) 5.4 Mexico Alzheimer’s Disease Drug Sales and Growth (2012-2017) 6 Europe Alzheimer’s Disease Drug by Countries 6.1 Europe Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries 6.1.1 Europe Alzheimer’s Disease Drug Sales by Countries (2012-2017) 6.1.2 Europe Alzheimer’s Disease Drug Revenue by Countries (2012-2017) 6.2 Germany Alzheimer’s Disease Drug Sales and Growth (2012-2017) 6.3 UK Alzheimer’s Disease Drug Sales and Growth (2012-2017) 6.4 France Alzheimer’s Disease Drug Sales and Growth (2012-2017) 6.5 Russia Alzheimer’s Disease Drug Sales and Growth (2012-2017) 6.6 Italy Alzheimer’s Disease Drug Sales and Growth (2012-2017) 7 Asia-Pacific Alzheimer’s Disease Drug by Countries 7.1 Asia-Pacific Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Alzheimer’s Disease Drug Sales by Countries (2012-2017) 7.1.2 Asia-Pacific Alzheimer’s Disease Drug Revenue by Countries (2012-2017) 7.2 China Alzheimer’s Disease Drug Sales and Growth (2012-2017) 7.3 Japan Alzheimer’s Disease Drug Sales and Growth (2012-2017) 7.4 Korea Alzheimer’s Disease Drug Sales and Growth (2012-2017) 7.5 India Alzheimer’s Disease Drug Sales and Growth (2012-2017) 7.6 Southeast Asia Alzheimer’s Disease Drug Sales and Growth (2012-2017) 8 South America Alzheimer’s Disease Drug by Countries 8.1 South America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries 8.1.1 South America Alzheimer’s Disease Drug Sales by Countries (2012-2017) 8.1.2 South America Alzheimer’s Disease Drug Revenue by Countries (2012-2017) 8.2 Brazil Alzheimer’s Disease Drug Sales and Growth (2012-2017) 8.3 Argentina Alzheimer’s Disease Drug Sales and Growth (2012-2017) 8.4 Columbia Alzheimer’s Disease Drug Sales and Growth (2012-2017) 9 Middle East and Africa Alzheimer’s Disease Drug by Countries 9.1 Middle East and Africa Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Alzheimer’s Disease Drug Sales by Countries (2012-2017) 9.1.2 Middle East and Africa Alzheimer’s Disease Drug Revenue by Countries (2012-2017) 9.2 Saudi Arabia Alzheimer’s Disease Drug Sales and Growth (2012-2017) 9.3 UAE Alzheimer’s Disease Drug Sales and Growth (2012-2017) 9.4 Egypt Alzheimer’s Disease Drug Sales and Growth (2012-2017) 9.5 Nigeria Alzheimer’s Disease Drug Sales and Growth (2012-2017) 9.6 South Africa Alzheimer’s Disease Drug Sales and Growth (2012-2017) 10 Global Alzheimer’s Disease Drug Market Segment by Type 10.1 Global Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017) 10.1.1 Global Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017) 10.1.2 Global Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017) 10.2 Donepezil Sales Growth and Price 10.2.1 Global Donepezil Sales Growth (2012-2017) 10.2.2 Global Donepezil Price (2012-2017) 10.3 Memantine Sales Growth and Price 10.3.1 Global Memantine Sales Growth (2012-2017) 10.3.2 Global Memantine Price (2012-2017) 10.4 Rivastigmine Sales Growth and Price 10.4.1 Global Rivastigmine Sales Growth (2012-2017) 10.4.2 Global Rivastigmine Price (2012-2017) 11 Global Alzheimer’s Disease Drug Market Segment by Application 11.1 Global Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017) 11.2 Early to Moderate Stages Sales Growth (2012-2017) 11.3 Moderate to Severe Stages Sales Growth (2012-2017) 12 Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.1 Global Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017-2022) 12.2 Alzheimer’s Disease Drug Market Forecast by Regions (2017-2022) 12.2.1 North America Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.2.2 Europe Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.2.3 Asia-Pacific Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.2.4 South America Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.2.5 Middle East and Africa Alzheimer’s Disease Drug Market Forecast (2017-2022) 12.3 Alzheimer’s Disease Drug Market Forecast by Type (2017-2022) 12.4 Alzheimer’s Disease Drug Market Forecast by Application (2017-2022) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Alzheimer’s Disease Drug Picture Table Product Specifications of Alzheimer’s Disease Drug Figure Global Sales Market Share of Alzheimer’s Disease Drug by Types in 2016 Table Alzheimer’s Disease Drug Types for Major Manufacturers Figure Donepezil Picture Figure Memantine Picture Figure Rivastigmine Picture Table Alzheimer’s Disease Drug Sales Market Share by Applications in 2016 Figure Early to Moderate Stages Picture Figure Moderate to Severe Stages Picture Figure USA Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Canada Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Mexico Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Germany Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure France Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure UK Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Russia Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Italy Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure China Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Japan Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Korea Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure India Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Southeast Asia Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Brazil Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Alzheimer’s Disease Drug Revenue (Value) and Growth Rate (2012-2022) Table Allergan Basic Information, Manufacturing Base and Competitors Table Allergan Alzheimer’s Disease Drug Type and Applications Table Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eisai Basic Information, Manufacturing Base and Competitors Table Eisai Alzheimer’s Disease Drug Type and Applications Table Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Alzheimer’s Disease Drug Type and Applications Table Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Alzheimer’s Disease Drug Type and Applications Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merz Pharma Basic Information, Manufacturing Base and Competitors Table Merz Pharma Alzheimer’s Disease Drug Type and Applications Table Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Alzheimer’s Disease Drug Type and Applications Table Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Alzheimer’s Disease Drug Type and Applications Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Lundbeck. Basic Information, Manufacturing Base and Competitors Table Lundbeck. Alzheimer’s Disease Drug Type and Applications Table Lundbeck. Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Alzheimer’s Disease Drug Sales by Manufacturer (2016-2017) Figure Global Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2016 Figure Global Alzheimer’s Disease Drug Sales Market Share by Manufacturer in 2017 Table Global Alzheimer’s Disease Drug Revenue by Manufacturer (2016-2017) Figure Global Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2016 Figure Global Alzheimer’s Disease Drug Revenue Market Share by Manufacturer in 2017 Figure Global Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Global Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table Global Alzheimer’s Disease Drug Sales by Regions (2012-2017) Table Global Alzheimer’s Disease Drug Sales Market Share by Regions (2012-2017) Table Global Alzheimer’s Disease Drug Revenue by Regions (2012-2017) Table Global Alzheimer’s Disease Drug Revenue Market Share by Regions in 2012 Table Global Alzheimer’s Disease Drug Revenue Market Share by Regions in 2016 Figure North America Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Europe Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Asia-Pacific Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure South America Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Middle East and Africa Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure North America Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table North America Alzheimer’s Disease Drug Sales by Countries (2012-2017) Table North America Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Figure North America Alzheimer’s Disease Drug Sales Market Share by Countries in 2012 Figure North America Alzheimer’s Disease Drug Sales Market Share by Countries in 2016 Table North America Alzheimer’s Disease Drug Revenue by Countries (2012-2017) Table North America Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017) Figure North America Alzheimer’s Disease Drug Revenue Market Share by Countries in 2012 Figure North America Alzheimer’s Disease Drug Revenue Market Share by Countries in 2016 Figure USA Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Canada Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Mexico Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Europe Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table Europe Alzheimer’s Disease Drug Sales by Countries (2012-2017) Table Europe Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Table Europe Alzheimer’s Disease Drug Revenue by Countries (2012-2017) Table Europe Alzheimer’s Disease Drug Revenue Market Share by Countries in 2012 Table Europe Alzheimer’s Disease Drug Revenue Market Share by Countries in 2016 Figure Germany Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure UK Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure France Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Russia Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Italy Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Asia-Pacific Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table Asia-Pacific Alzheimer’s Disease Drug Sales by Countries (2012-2017) Table Asia-Pacific Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Table Asia-Pacific Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Table Asia-Pacific Alzheimer’s Disease Drug Revenue by Countries (2012-2017) Table Asia-Pacific Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017) Figure China Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Japan Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Korea Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure India Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Southeast Asia Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure South America Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table South America Alzheimer’s Disease Drug Sales by Countries (2012-2017) Table South America Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Figure South America Alzheimer’s Disease Drug Sales Market Share by Countries in 2016 Table South America Alzheimer’s Disease Drug Revenue by Countries (2012-2017) Table South America Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017) Figure South America Alzheimer’s Disease Drug Revenue Market Share by Countries in 2012 Figure South America Alzheimer’s Disease Drug Revenue Market Share by Countries in 2016 Figure Brazil Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Argentina Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Columbia Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Middle East and Africa Alzheimer’s Disease Drug Revenue and Growth (2012-2017) Table Middle East and Africa Alzheimer’s Disease Drug Sales by Countries (2012-2017) Table Middle East and Africa Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Alzheimer’s Disease Drug Sales Market Share by Countries in 2016 Table Middle East and Africa Alzheimer’s Disease Drug Revenue by Countries (2012-2017) Table Middle East and Africa Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Alzheimer’s Disease Drug Revenue Market Share by Countries in 2012 Figure Middle East and Africa Alzheimer’s Disease Drug Revenue Market Share by Countries in 2016 Figure Saudi Arabia Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure UAE Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Egypt Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure Nigeria Alzheimer’s Disease Drug Sales and Growth (2012-2017) Figure South Africa Alzheimer’s Disease Drug Sales and Growth (2012-2017) Table Global Alzheimer’s Disease Drug Sales by Type (2012-2017) Table Global Alzheimer’s Disease Drug Sales Share by Type (2012-2017) Table Global Alzheimer’s Disease Drug Revenue by Type (2012-2017) Table Global Alzheimer’s Disease Drug Revenue Share by Type (2012-2017) Figure Global Donepezil Sales Growth (2012-2017) Figure Global Donepezil Price (2012-2017) Figure Global Memantine Sales Growth (2012-2017) Figure Global Memantine Price (2012-2017) Figure Global Rivastigmine Sales Growth (2012-2017) Figure Global Rivastigmine Price (2012-2017) Table Global Alzheimer’s Disease Drug Sales by Application (2012-2017) Table Global Alzheimer’s Disease Drug Sales Share by Application (2012-2017) Figure Global Early to Moderate Stages Sales Growth (2012-2017) Figure Global Moderate to Severe Stages Sales Growth (2012-2017) Figure Global Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2017 -2022) Table Global Alzheimer’s Disease Drug Sales Forecast by Regions (2017-2022) Table Global Alzheimer’s Disease Drug Market Share Forecast by Regions (2017-2022) Figure North America Sales Alzheimer’s Disease Drug Market Forecast (2017-2022) Figure Europe Sales Alzheimer’s Disease Drug Market Forecast (2017-2022) Figure Asia-Pacific Sales Alzheimer’s Disease Drug Market Forecast (2017-2022) Figure South America Sales Alzheimer’s Disease Drug Market Forecast (2017-2022) Figure Middle East and Africa Sales Alzheimer’s Disease Drug Market Forecast (2017-2022) Table Global Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022) Table Global Alzheimer’s Disease Drug Market Share Forecast by Type (2017-2022) Table Global Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022) Table Global Alzheimer’s Disease Drug Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List